SPERA PHARMA INC. is a Japan-based pharmaceutical contract development and manufacturing company pioneering advanced analytical technologies such as MicroED (Microcrystal Electron Diffraction), alongside drug formulation, process development, and comprehensive analysis services. With a mission to accelerate drug discovery, the company supports clients from early research to clinical stages. SPERA PHARMA leverages cutting-edge methods including flow chemistry, solid form science, and nano-formulation to optimize drug candidates at the molecular level. Through innovation, quality, and a strong commitment to social responsibility, SPERA PHARMA contributes to the advancement of global healthcare.

Discover SPERA PHARMA’s advanced drug development capabilities, including MicroED for structural analysis, flow chemistry for efficient synthesis, and cutting-edge formulation technologies. We provide end-to-end CDMO services to accelerate your pharmaceutical pipeline with precision and reliability.